Combination Adjuvants Enhance Recombinant Protein Vaccine Protection against Fungal Infection
Open Access
- 31 August 2021
- journal article
- research article
- Published by American Society for Microbiology in mBio
- Vol. 12 (4) , e0201821
Abstract
Fungal disease remains a challenging clinical and public health problem. Despite medical advances, invasive fungal infections have skyrocketed over the last decade and pose a mounting health threat in immunocompetent and -deficient hosts, with worldwide mortality rates ranking 7th, even ahead of tuberculosis.Keywords
All Related Versions
Funding Information
- HHS | NIH | National Institute of Allergy and Infectious Diseases (AI093553)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (AI035681, AI040996)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (HHSN272201800044C, HHS-N272201400053C, HHS-N272200800039C, U01-AI061142)
This publication has 27 references indexed in Scilit:
- Hidden Killers: Human Fungal InfectionsScience Translational Medicine, 2012
- Advax™, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responsesVaccine, 2012
- Tackling Human Fungal InfectionsScience, 2012
- Adaptive Immunity to FungiAnnual Review of Immunology, 2012
- Immunity to fungal infectionsNature Reviews Immunology, 2011
- CD8+ Cells Enhance Resistance to Pulmonary Serotype 3 Streptococcus pneumoniae Infection in MiceThe Journal of Immunology, 2011
- Inhibition of T Cells Provides Protection against Early Invasive Pneumococcal DiseaseInfection and Immunity, 2010
- IL‐23 and the Th17 pathway promote inflammation and impair antifungal immune resistanceEuropean Journal of Immunology, 2007
- Vaccine Immunity to Pathogenic Fungi Overcomes the Requirement for CD4 Help in Exogenous Antigen Presentation to CD8+ T CellsJournal of Experimental Medicine, 2003
- Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte ResponsesJournal of Experimental Medicine, 2001